Outcome of Board Meeting
Outcome of Board Meeting
Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.